Growth Metrics

Heartflow (HTFL) Current Deferred Revenue (2023 - 2025)

Heartflow's quarterly Current Deferred Revenue came in at $627000.0 in Q4 2025, down 39.77% year-on-year from $1.0 million in Q4 2024, and down 39.77% quarter-over-quarter from $1.0 million in Q4 2024.

Heartflow has reported Current Deferred Revenue for 3 years, with the latest figure at $627000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue fell 39.77% year-over-year to $627000.0; the trailing twelve-month figure through Dec 2025 stood at $627000.0 (down 39.77% YoY), and the FY2025 full-year result was $627000.0, down 39.77% from the prior year.
  • Current Deferred Revenue for Q4 2025 stood at $627000.0, down from $1.0 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $1.0 million in Q4 2024, with the low at $498000.0 in Q4 2023.
  • Average Current Deferred Revenue over 3 years is $722000.0, with a median of $627000.0 recorded in 2025.
  • Year-over-year, Current Deferred Revenue jumped 109.04% in 2024 and tumbled 39.77% in 2025.
  • Tracing HTFL's Current Deferred Revenue over 3 years: stood at $498000.0 in 2023, then soared by 109.04% to $1.0 million in 2024, then plunged by 39.77% to $627000.0 in 2025.
  • The last three Current Deferred Revenue figures came in at $627000.0 (Q4 2025), $1.0 million (Q4 2024), and $498000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Heartflow 1.15 Bn 974.90 Mn 39.06 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 627,000.00
Dec 31, 2024 1.04 Mn
Dec 31, 2023 498,000.00